Reproductive health in women following abdominal organ transplant.
Fertility is commonly impaired in women with end-stage kidney and liver disease, although most women will have restoration of fertility within 1 year of transplant. Family planning is therefore critical to discuss with reproductive-aged transplant recipients in the early posttransplant period, in order to ensure timely initiation of contraception, and optimal timing for conception. For women seeking pregnancy, the risks to the mother, graft, and baby should be discussed, including evaluation of immunosuppression safety and potential for adjusting medications prior to conception. With an increasing number of transplant patients now breastfeeding, immunosuppression safety in lactation continues to carry great importance.
['Sarkar|Monika|M|0000-0003-4233-1062', 'Bramham|Kate|K|0000-0002-6272-7921', 'Moritz|Michael J|MJ|0000-0002-6482-3546', 'Coscia|Lisa|L|']
D005260:Female D006801:Humans D016030:Kidney Transplantation D016031:Liver Transplantation D011247:Pregnancy D011248:Pregnancy Complications D011256:Pregnancy Outcome D060728:Reproductive Health
liver disease pregnancy clinical research/practice kidney disease kidney transplantation/nephrology liver transplantation/hepatology obstetrics and gynecology patient safety reproductive biology